• Technical Name
  • Influenza mucosal vaccine compositionpreparationapplication thereof
  • Operator
  • National Tsing Hua University
  • Booth
  • Precision Health Ecosystem
  • Contact
  • 吳夙欽
  • Email
  • scwu@life.nthu.edu.tw
Technical Description Provided is an influenza mucosal vaccine compositionpreparationapplication thereof. This composition contains an antigen fusion protein which includes an influenza virus antigena Type IIb heat-labile enterotoxin A subunit. Immunization with the antigen fusion protein induces cellularhumoral immune responses, including systemicmucosal immune responses, against a specific in
Scientific Breakthrough Provided is an influenza mucosal vaccine compositionpreparationapplication thereof. This composition contains an antigen fusion protein which includes an influenza virus antigena Type IIb heat-labile enterotoxin A subunit. Immunization with the antigen fusion protein induces cellularhumoral immune responses, including systemicmucosal immune responses, against a specific in
Industrial Applicability The market for seasonal influenza vaccines, sized at US$2.8 billion in 2008–2009 across the major markets, not including the potential of pandemic vaccines. The annual rate of influenza vaccine is approximately 12.6. Our invention provides a mucosal vaccine composition for both humanpoultry vaccine markets. Our invention has already been granted for the patents in USTaiwan.
本網站使用您的Cookie於優化網站。繼續瀏覽網站即表示您同意本公司隱私權政策,您可至隱私權政策了解詳細資訊。